Gilead Sciences, Inc. (GILD) stock
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 12/30102% above fair value
$168.98−1.28 (-0.75%)
Close on Nov 18, 2026Market cap $209.59BP/E –Yield 1.87%
Gilead Sciences shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Gilead Sciences's shares outstanding was 1.25B at Sep 30, 2026. For fiscal 2025 it was 1.25B, up 0.0% from the year before. Over ten years it grew -1.9% a year on average. The highest annual figure on record is 1.93B in fiscal 2007.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.25B | 0.0% |
| FY2024 | Dec 31, 2024 | 1.25B | -0.2% |
| FY2023 | Dec 31, 2023 | 1.26B | -0.3% |
| FY2022 | Dec 31, 2022 | 1.26B | 0.0% |
| FY2021 | Dec 31, 2021 | 1.26B | -0.1% |
| FY2020 | Dec 31, 2020 | 1.26B | -1.1% |
| FY2019 | Dec 31, 2019 | 1.28B | -2.4% |
| FY2018 | Dec 31, 2018 | 1.31B | -0.8% |
| FY2017 | Dec 31, 2017 | 1.32B | -2.9% |
| FY2016 | Dec 31, 2016 | 1.36B | -10.7% |
| FY2015 | Dec 31, 2015 | 1.52B | -7.7% |
| FY2014 | Dec 31, 2014 | 1.65B | -2.8% |
| FY2013 | Dec 31, 2013 | 1.70B | +7.1% |
| FY2012 | Dec 31, 2012 | 1.58B | +0.2% |
| FY2011 | Dec 31, 2011 | 1.58B | -9.5% |
| FY2010 | Dec 31, 2010 | 1.75B | -6.5% |
| FY2009 | Dec 31, 2009 | 1.87B | -2.6% |
| FY2008 | Dec 31, 2008 | 1.92B | -0.6% |
| FY2007 | Dec 31, 2007 | 1.93B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 1.25B | -0.2% |
| Q2 FY2026 | Jun 30, 2026 | 1.24B | -1.0% |
| Q1 FY2026 | Mar 31, 2026 | 1.25B | -0.4% |
| Q4 FY2025 | Dec 31, 2025 | 1.25B | -2.1% |
| Q3 FY2025 | Sep 30, 2025 | 1.25B | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | 1.25B | +0.3% |
| Q1 FY2025 | Mar 31, 2025 | 1.26B | +1.0% |
| Q4 FY2024 | Dec 31, 2024 | 1.28B | +1.9% |
| Q3 FY2024 | Sep 30, 2024 | 1.25B | -0.2% |
| Q2 FY2024 | Jun 30, 2024 | 1.25B | -0.6% |
| Q1 FY2024 | Mar 31, 2024 | 1.25B | -1.1% |
| Q4 FY2023 | Dec 31, 2023 | 1.25B | -0.8% |
| Q3 FY2023 | Sep 30, 2023 | 1.26B | -0.3% |
| Q2 FY2023 | Jun 30, 2023 | 1.26B | -0.2% |
| Q1 FY2023 | Mar 31, 2023 | 1.26B | -0.1% |
| Q4 FY2022 | Dec 31, 2022 | 1.26B | +0.2% |
| Q3 FY2022 | Sep 30, 2022 | 1.26B | -0.1% |
| Q2 FY2022 | Jun 30, 2022 | 1.26B | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | 1.26B | 0.0% |
| Q4 FY2021 | Dec 31, 2021 | 1.26B | -1.5% |
| Q3 FY2021 | Sep 30, 2021 | 1.26B | +0.1% |
| Q2 FY2021 | Jun 30, 2021 | 1.26B | +0.4% |
| Q1 FY2021 | Mar 31, 2021 | 1.26B | -0.6% |
| Q4 FY2020 | Dec 31, 2020 | 1.28B | +0.5% |
| Q3 FY2020 | Sep 30, 2020 | 1.26B | -0.5% |
| Q2 FY2020 | Jun 30, 2020 | 1.25B | -1.7% |
| Q1 FY2020 | Mar 31, 2020 | 1.27B | -1.0% |
| Q4 FY2019 | Dec 31, 2019 | 1.27B | -1.5% |
| Q3 FY2019 | Sep 30, 2019 | 1.27B | -3.1% |
| Q2 FY2019 | Jun 30, 2019 | 1.28B | -2.4% |
| Q1 FY2019 | Mar 31, 2019 | 1.28B | -2.8% |
| Q4 FY2018 | Dec 31, 2018 | 1.29B | -2.0% |
| Q3 FY2018 | Sep 30, 2018 | 1.31B | -0.9% |
| Q2 FY2018 | Jun 30, 2018 | 1.31B | -0.7% |
| Q1 FY2018 | Mar 31, 2018 | 1.32B | 0.0% |
| Q4 FY2017 | Dec 31, 2017 | 1.32B | -0.5% |
| Q3 FY2017 | Sep 30, 2017 | 1.32B | – |
| Q2 FY2017 | Jun 30, 2017 | 1.32B | – |
| Q1 FY2017 | Mar 31, 2017 | 1.32B | – |
| Q4 FY2016 | Dec 31, 2016 | 1.32B | – |
See a number that looks wrong?